SUPERWISE® and Renova Health Join Forces to Transform Chronic Care with Real-Time, AI-Powered Patient Engagement
'We did not just deploy tools—we embedded real-time intelligence into care workflows, and ensured every innovation met the highest standards of compliance and trust. This is AI not just working—but working for people,' said Russ Blattner, CEO, SUPERWISE. Share
SUPERWISE's strategic deployment significantly enhances Renova Health's chronic care management by injecting AI-driven insights that streamline documentation, empower care managers, and facilitate more human-centered healthcare, especially in underserved communities.
SUPERWISE® Identifies and Solves a Critical Gap: Unlocking Vital Insights Between Patient Visits
SUPERWISE's deep understanding of healthcare operations led to the identification of a significant opportunity within Renova Health's patient engagement model. While Renova's dedicated care managers frequently gathered critical, valuable patient insights during direct conversations and check-in calls, these unstructured details often remained outside the Electronic Medical Record (EMR). SUPERWISE recognized that these spontaneous human interactions held the key to a truly comprehensive patient understanding.
To unlock this untapped potential, SUPERWISE collaborated closely with Renova Health, strategically integrating its AI directly into Renova's existing workflows. This innovative approach, championed by SUPERWISE, now enables Renova Health to capture and structure those critical insights in real time. Instead of relying solely on typed forms, SUPERWISE AI flags relevant patterns, guides next steps, and even helps draft clinical notes during the call. This powerful capability actively supports Renova's care managers, ensuring crucial information is never missed. The result for Renova Health is better documentation, a significant reduction in manual administrative burden, and a clearer, more efficient path to proactive, whole-person care for their patients.
'Our work with Renova Health exemplifies what's possible when SUPERWISE AI is implemented with purpose,' said Russ Blattner, CEO of SUPERWISE. 'We did not just deploy tools—we unified fragmented systems, embedded real-time intelligence into care workflows, and ensured every innovation met the highest standards of compliance and trust. This is AI not just working—but working for people.'
SUPERWISE, recently recognized by Gartner in its Hype Cycle for Artificial Intelligence as a "Cool Vendor" in Enterprise AI Governance and by Forrester The AI Governance Solutions Landscape, Q2 2025, brings unparalleled transparency, reliability, and real-time observability to complex AI ecosystems. By integrating its platform into Renova's R‑Care system, SUPERWISE empowers Renova's care teams with intelligent insights while ensuring every AI model is explainable, HIPAA compliant, and aligned to clinical standards. This successful client implementation marks a critical step toward modernizing healthcare infrastructure, laying the groundwork for scalable innovation across chronic care, population health, and the future of AI-driven clinical operations.
'Our goal has always been to put patients first,' said Dave Jacobs, CEO of Renova Health. 'By leveraging SUPERWISE's cutting-edge solutions, we blend real-time data, intelligent systems, and personalized engagement to deliver the right care—at the right time—for the right patient, without losing the human touch. This is how we are transforming care delivery across every community we serve—urban, suburban, and rural.'
Key Benefits Delivered by SUPERWISE to Renova Health:
Real-time documentation and AI-assisted clinical notes streamline workflows and improve data capture during patient interactions.
streamline workflows and improve data capture during patient interactions. AI-personalized engagement enhances patient care by guiding Care Managers with insights typically reserved for physicians.
enhances patient care by guiding Care Managers with insights typically reserved for physicians. Reduced administrative burden empowers care teams to focus more on patient relationships and less on paperwork.
empowers care teams to focus more on patient relationships and less on paperwork. Strengthened AI governance, risk, and compliance (GRC) ensures that all innovations meet healthcare's highest regulatory standards
This SUPERWISE driven solution not only improves chronic care outcomes for Renova Health but also offers a scalable blueprint for safely deploying AI in highly regulated clinical environments. With SUPERWISE's foundational support and continued investment in its R‑Care platform, Renova Health is building toward real-time, AI-informed patient support at scale. This successful client engagement has already drawn interest from pharmaceutical innovators and may help shape the next generation of both traditional and integrative medicine.
About SUPERWISE®
SUPERWISE is the Enterprise AI Governance and Operations Platform purpose-built for real-world deployment. With a platform-first approach, SUPERWISE unifies AI observability, risk management, and operational oversight—giving complex industries the tools to deploy, monitor, and govern AI at scale. Recognized by Gartner as a Cool Vendor in Enterprise AI Governance and a pioneer in MLOps, SUPERWISE provides built-in guardrails, explainability, and compliance features that ensure AI is not only powerful—but trusted. From regulated sectors like healthcare and finance to large-scale enterprise teams, SUPERWISE enables confident, compliant, and continuous AI performance. To learn more, visit https://superwise.ai/renova-case-study/
About Renova Health
Renova Health is a chronic care management provider focused on improving patient engagement and health outcomes, across diverse populations nationwide. Their proprietary RCare platform integrates clinical workflows and patient data to deliver proactive, personalized care. Visit Renova at https://www.renovahealth.care/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
4 days ago
- Business Insider
Emerson Electric Company (EMR) Receives a Rating Update from a Top Analyst
In a report released today, Christopher Glynn from Oppenheimer maintained a Buy rating on Emerson Electric Company, with a price target of $152.00. The company's shares closed today at $132.74. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Glynn covers the Industrials sector, focusing on stocks such as Emerson Electric Company, Ametek, and Honeywell International. According to TipRanks, Glynn has an average return of 17.8% and a 65.32% success rate on recommended stocks. In addition to Oppenheimer, Emerson Electric Company also received a Buy from KeyBanc's Kenneth Newman in a report issued yesterday. However, on the same day, Barclays upgraded Emerson Electric Company (NYSE: EMR) to a Hold. Based on Emerson Electric Company's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $4.55 billion and a net profit of $586 million. In comparison, last year the company earned a revenue of $4.38 billion and had a net profit of $329 million Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EMR in relation to earlier this year. Most recently, in May 2025, Michael H. Train, the SVP & Chief Sustain Officer of EMR sold 28,305.00 shares for a total of $3,380,749.20.
Business Wire
7 days ago
- Business Wire
SUPERWISE® Recognized Across Four Gartner® Hype Cycles™ for 2025 for Leadership in Explainable AI
NASHVILLE, Tenn.--(BUSINESS WIRE)--SUPERWISE®, a leading provider of AI observability and model governance solutions, proudly announces its recognition as a Sample Vendor in Explainable AI (XAI) across four Gartner® Hype Cycle™ reports for 2025: Russ Blattner, CEO of SUPERWISE, commented: "Being named by Gartner® in four separate Hype Cycle™ reports is a powerful validation of our mission to make AI trustworthy and transparent." Share Hype Cycle™ for Legal, Risk, Compliance and Audit Technologies,2025, 28 July 2025 Hype Cycle™ for Local Government Technologies, 2025, 17 July 2025 Hype Cycle™ for Analytics and Business Intelligence,2025, 17 June 2025 Hype Cycle™ for Supply Chain Planning Technologies, 2025, 10 July 2025 We believe that this multi-sector recognition highlights SUPERWISE's growing influence in operationalizing trustworthy AI across regulated industries, public sector applications, and enterprise decision-making environments. In both the Legal and Local Government reports, Gartner analysts Peter Krensky and Sumit Agarwal define (XAI) Explainable AI as: 'A set of capabilities that describes a model, highlights its strengths and weaknesses, predicts its likely behavior and identifies any potential biases. It can clarify a model's functioning to a specific audience to enable accuracy, fairness, accountability, stability and transparency in algorithmic decision making.' Russ Blattner, CEO of SUPERWISE, commented: "Being named by Gartner® in four separate Hype Cycle™ reports is a powerful validation of our mission to make AI trustworthy and transparent. Whether it's a legal department managing risk, a local government deploying AI for public services, or a supply chain team optimizing decisions, explainability is no longer optional. It is essential. SUPERWISE is proud to be leading the way in operationalizing XAI across industries." With the recent addition of the Hype Cycle™ for Legal, Risk, Compliance and Audit Technologies and the Hype Cycle™ for Local Government Technologies, SUPERWISE is now featured across four Gartner® Hype Cycles™ for 2025. This includes earlier mentions in the Analytics and Business Intelligence report and the Hype Cycle™ for Supply Chain Planning Technologies, demonstrating continued recognition of the platform's enterprise impact. SUPERWISE's platform enables continuous monitoring, bias detection, and explainability throughout the AI lifecycle. From development to production, it helps organizations meet governance standards and build stakeholder trust. About SUPERWISE SUPERWISE is the Enterprise AI Governance and Operations Platform purpose-built for real-world AI. With a platform-first approach, SUPERWISE unifies AI operations and governance, risk, and compliance (GRC) into a single, scalable foundation—empowering complex, regulated industries to deploy, monitor, and manage AI with confidence and oversight. SUPERWISE was also included in the Forrester® AI Governance Solutions Landscape 2025, further validating its leadership in enabling transparent, accountable, and scalable AI governance. To learn more about SUPERWISE and its XAI capabilities, visit *Gartner Disclaimer: GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Yahoo
7 days ago
- Yahoo
Emerson Electric (NYSE:EMR) Misses Q2 Revenue Estimates, Stock Drops
Engineering and automation solutions company Emerson (NYSE:EMR) fell short of the market's revenue expectations in Q2 CY2025 as sales rose 3.9% year on year to $4.55 billion. On the other hand, the company expects next quarter's revenue to be around $4.90 billion, close to analysts' estimates. Its non-GAAP profit of $1.52 per share was in line with analysts' consensus estimates. Is now the time to buy Emerson Electric? Find out in our full research report. Emerson Electric (EMR) Q2 CY2025 Highlights: Revenue: $4.55 billion vs analyst estimates of $4.61 billion (3.9% year-on-year growth, 1.2% miss) Adjusted EPS: $1.52 vs analyst estimates of $1.51 (in line) Adjusted EBITDA: $1.23 billion vs analyst estimates of $1.30 billion (27.1% margin, 4.9% miss) Revenue Guidance for Q3 CY2025 is $4.90 billion at the midpoint, roughly in line with what analysts were expecting Management slightly raised its full-year Adjusted EPS guidance to $6 at the midpoint Operating Margin: 24.8%, up from 19.2% in the same quarter last year Free Cash Flow Margin: 21.5%, down from 22.8% in the same quarter last year Market Capitalization: $79.07 billion "Emerson's solid third quarter results reflect our sustained momentum, delivering strong underlying growth, profitability and cash flow, which we expect to continue as we finish the fiscal year," said Emerson President and Chief Executive Officer Lal Karsanbhai. Company Overview Founded in 1890, Emerson Electric (NYSE:EMR) is a multinational technology and engineering company providing solutions in the industrial, commercial, and residential markets. Revenue Growth A company's long-term sales performance can indicate its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Unfortunately, Emerson Electric struggled to consistently increase demand as its $17.78 billion of sales for the trailing 12 months was close to its revenue five years ago. This wasn't a great result and is a sign of lacking business quality. We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. Emerson Electric's annualized revenue growth of 9% over the last two years is above its five-year trend, suggesting some bright spots. We also think Emerson Electric's recent performance stands out as many other Internet of Things businesses have faced declining sales because of cyclical headwinds. This quarter, Emerson Electric's revenue grew by 3.9% year on year to $4.55 billion, falling short of Wall Street's estimates. Company management is currently guiding for a 6% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 5.9% over the next 12 months, a deceleration versus the last two years. This projection doesn't excite us and implies its products and services will see some demand headwinds. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Operating Margin Emerson Electric has been a well-oiled machine over the last five years. It demonstrated elite profitability for an industrials business, boasting an average operating margin of 18.5%. This result isn't surprising as its high gross margin gives it a favorable starting point. Looking at the trend in its profitability, Emerson Electric's operating margin rose by 2.7 percentage points over the last five years, showing its efficiency has improved. In Q2, Emerson Electric generated an operating margin profit margin of 24.8%, up 5.6 percentage points year on year. The increase was solid, and because its operating margin rose more than its gross margin, we can infer it was more efficient with expenses such as marketing, R&D, and administrative overhead. Earnings Per Share We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company's growth is profitable. Emerson Electric's EPS grew at a solid 11.3% compounded annual growth rate over the last five years, higher than its flat revenue. This tells us management responded to softer demand by adapting its cost structure. Diving into Emerson Electric's quality of earnings can give us a better understanding of its performance. As we mentioned earlier, Emerson Electric's operating margin expanded by 2.7 percentage points over the last five years. On top of that, its share count shrank by 5.9%. These are positive signs for shareholders because improving profitability and share buybacks turbocharge EPS growth relative to revenue growth. Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business. For Emerson Electric, its two-year annual EPS growth of 11.8% is similar to its five-year trend, implying strong and stable earnings power. In Q2, Emerson Electric reported adjusted EPS at $1.52, up from $1.43 in the same quarter last year. This print was close to analysts' estimates. Over the next 12 months, Wall Street expects Emerson Electric's full-year EPS of $5.86 to grow 8.5%. Key Takeaways from Emerson Electric's Q2 Results We struggled to find many positives in these results. Its EBITDA missed and its revenue fell slightly short of Wall Street's estimates. Overall, this quarter could have been better. The stock traded down 6.8% to $130.84 immediately after reporting. Emerson Electric may have had a tough quarter, but does that actually create an opportunity to invest right now? If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free.
